0001209191-20-065508.txt : 20201230
0001209191-20-065508.hdr.sgml : 20201230
20201230161433
ACCESSION NUMBER: 0001209191-20-065508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201228
FILED AS OF DATE: 20201230
DATE AS OF CHANGE: 20201230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Armstrong Christopher R
CENTRAL INDEX KEY: 0001775448
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38467
FILM NUMBER: 201426019
MAIL ADDRESS:
STREET 1: C/O CERIDIAN HCM HOLDING INC.
STREET 2: 3311 EAST OLD SHAKOPEE ROAD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55425
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ceridian HCM Holding Inc.
CENTRAL INDEX KEY: 0001725057
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 463231686
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3311 EAST OLD SHAKOPEE ROAD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55425
BUSINESS PHONE: 952-853-8100
MAIL ADDRESS:
STREET 1: 3311 EAST OLD SHAKOPEE ROAD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55425
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-28
0
0001725057
Ceridian HCM Holding Inc.
CDAY
0001775448
Armstrong Christopher R
C/O CERIDIAN HCM HOLDING INC.
3311 E. OLD SHAKOPEE ROAD
MINNEAPOLIS
MN
55425
0
1
0
0
EVP, Chief Customer Officer
Common Stock
2020-12-28
4
M
0
6321
16.74
A
75164
D
Common Stock
2020-12-28
4
M
0
8720
17.20
A
83884
D
Common Stock
2020-12-28
4
M
0
16983
22.00
A
100867
D
Common Stock
2020-12-28
4
S
0
17979
106.96
D
82888
D
Common Stock
2020-12-28
4
S
0
6865
107.75
D
76023
D
Common Stock
2020-12-28
4
S
0
6123
109.44
D
69900
D
Common Stock
2020-12-28
4
S
0
800
110.28
D
69100
D
Common Stock
2020-12-28
4
S
0
257
111.06
D
68843
D
Option (right to buy)
16.74
2020-12-28
4
M
0
6321
D
2026-06-01
Common Stock
6321
0
D
Option (right to buy)
17.20
2020-12-28
4
M
0
8720
D
2027-04-27
Common Stock
8720
2907
D
Option (right to buy)
22.00
2020-12-28
4
M
0
16983
D
2028-04-25
Common Stock
16983
50952
D
Option (right to buy)
44.91
2029-02-08
Common Stock
50000
50000
D
Option (right to buy)
44.91
2029-02-08
Common Stock
2301
2301
D
Option (right to buy)
65.26
2030-05-08
Common Stock
107244
107244
D
Performance Units
2021-03-01
Common Stock
3382
3382
D
The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.426 to $107.41 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.445 to $108.065 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.93 to $109.92 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.95 to $110.53 inclusive. The reporting person undertakes to provide Ceridian HCM Holding Inc., any security holder of Ceridian HCM Holding Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes (i) 18,313 shares of common stock, (ii) 37,500 shares issuable pursuant to Restricted Stock Units, granted on February 8, 2019, that vest in three annual installments beginning on February 8, 2021, (ii) 1,538 shares that are issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iv) 11,492 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021.
Fully vested and exercisable.
Not Applicable
Consists of 33,967 vested and exercisable options as of April 25, 2020, of which 16,983 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 33,968 options that vest and become exercisable in two annual installments beginning on April 25, 2021.
Consists of 12,500 vested and exercisable options as of February 8, 2020 and 37,500 options that vest and become exercisable in three annual installments beginning on February 8, 2021.
Consists of 575 vested and exercisable options as of February 8, 2020 and 1,726 options that vest and become exercisable in three annual installments beginning on February 8, 2021.
These options vest and become exercisable in four annual installments beginning on May 8, 2021.
Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.
For Christopher Armstrong, pursuant to the Power of Attorney previously filed.
/s/ William E. McDonald, attorney-in-fact
2020-12-30